Dr. Arvind Chakravarthy, MD, MBA is a physician-executive, entrepreneur, and thought leader advancing the next generation of longevity care through Medicine 4.0. As Founder and Chairman of RegenTherapy™ and Co-Founder of RegenQuantum™, he is focused on transforming healthcare from symptom management to proactive, regenerative optimization. His work centers on cellular and mitochondrial health, leveraging quantum cell factors, targeted peptides, hormone optimization, and precision diagnostics to enhance performance, resilience, and long-term healthspan.


Dr. Chakravarthy’s approach integrates the Five Pillars of Health within a closed-loop model that combines advanced lab testing, biologic signaling therapies, lifestyle optimization, and continuous data feedback. Through AI-enabled insights, telehealth infrastructure, and strategic clinical partnerships, he is building a scalable B2B2C platform that empowers physicians and health organizations to deliver personalized, high-impact longevity programs across the United States.


With a background spanning clinical medicine, business strategy, and operational leadership, Dr. Chakravarthy leads enterprise growth, physician education, and strategic partnerships across a rapidly expanding network of clinics, telehealth providers, and performance-focused organizations. His vision is to create a vertically integrated longevity ecosystem that aligns diagnostics, therapeutics, distribution, and care delivery under a unified regenerative framework.


Driven by a mission to extend healthspan and optimize human potential, Dr. Chakravarthy is committed to redefining the future of healthcare through precision, scalability, and biologic innovation that delivers measurable outcomes for patients, partners, and populations.